Immune Netw.  2024 Apr;24(2):e16. 10.4110/in.2024.24.e16.

Beyond the CAR T Cells: TIL Therapy for Solid Tumors

Affiliations
  • 1Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang 10408, Korea

Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr